Imperva (IMPV) Rating Lowered to Underweight at J P Morgan Chase & Co

Imperva (NASDAQ:IMPV) was downgraded by equities research analysts at J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a report issued on Tuesday. They presently have a $45.00 price target on the software maker’s stock. J P Morgan Chase & Co’s target price would suggest a potential upside of 10.29% from the stock’s previous close.

IMPV has been the topic of a number of other research reports. BidaskClub raised shares of Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, August 22nd. Zacks Investment Research raised shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price on the stock in a research report on Tuesday, October 24th. Morgan Stanley reaffirmed an “underweight” rating and set a $39.00 target price on shares of Imperva in a research report on Thursday, November 9th. Wells Fargo & Company lowered shares of Imperva from an “outperform” rating to a “market perform” rating in a research report on Monday, October 9th. Finally, Piper Jaffray Companies set a $58.00 target price on shares of Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $51.86.

Imperva (NASDAQ IMPV) opened at $40.80 on Tuesday. Imperva has a 52-week low of $35.80 and a 52-week high of $52.40.

Imperva (NASDAQ:IMPV) last announced its earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The business had revenue of $83.89 million for the quarter, compared to analyst estimates of $83.79 million. During the same quarter in the previous year, the firm posted $0.08 earnings per share. Imperva’s revenue was up 22.6% compared to the same quarter last year. sell-side analysts anticipate that Imperva will post -0.52 earnings per share for the current year.

A number of institutional investors have recently made changes to their positions in the business. Van ECK Associates Corp grew its holdings in shares of Imperva by 0.8% in the 2nd quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock worth $399,000 after purchasing an additional 64 shares during the last quarter. Comerica Bank grew its holdings in shares of Imperva by 0.8% in the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock worth $978,000 after purchasing an additional 157 shares during the last quarter. Ameritas Investment Partners Inc. grew its holdings in shares of Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock worth $141,000 after purchasing an additional 464 shares during the last quarter. Aperio Group LLC grew its holdings in shares of Imperva by 8.1% in the 2nd quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock worth $340,000 after purchasing an additional 531 shares during the last quarter. Finally, Parametric Portfolio Associates LLC grew its holdings in shares of Imperva by 5.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock worth $556,000 after purchasing an additional 581 shares during the last quarter. 96.95% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Imperva (IMPV) Rating Lowered to Underweight at J P Morgan Chase & Co” was originally posted by Week Herald and is owned by of Week Herald. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://weekherald.com/2017/12/14/imperva-impv-rating-lowered-to-underweight-at-j-p-morgan-chase-co.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply